111, Inc. (NASDAQ:YI) Short Interest Update

111, Inc. (NASDAQ:YI) saw a significant decrease in short interest in March. As of March 31st, there was short interest totalling 29,800 shares, a decrease of 39.1% from the March 15th total of 48,900 shares. Based on an average trading volume of 74,800 shares, the short-interest ratio is currently 0.4 days.

111 Stock Up 2.8 %

YI stock opened at $1.10 on Friday. The firm has a market cap of $91.87 million, a PE ratio of -1.67 and a beta of 0.38. The business has a 50 day moving average of $1.31 and a 200-day moving average of $1.73. 111 has a 12-month low of $0.98 and a 12-month high of $3.36.

111 (NASDAQ:YI) last released its earnings results on Thursday, March 21st. The company reported ($0.34) earnings per share (EPS) for the quarter. The firm had revenue of $578.69 million during the quarter.

Hedge Funds Weigh In On 111

Institutional investors have recently modified their holdings of the business. Prelude Capital Management LLC purchased a new position in 111 in the third quarter valued at approximately $291,000. State Street Corp lifted its stake in 111 by 5.4% in the first quarter. State Street Corp now owns 87,669 shares of the company’s stock valued at $232,000 after purchasing an additional 4,455 shares during the last quarter. Renaissance Technologies LLC lifted its stake in 111 by 231.0% in the second quarter. Renaissance Technologies LLC now owns 109,047 shares of the company’s stock valued at $225,000 after purchasing an additional 76,100 shares during the last quarter. Invesco Ltd. lifted its stake in 111 by 59.0% in the first quarter. Invesco Ltd. now owns 52,423 shares of the company’s stock valued at $139,000 after purchasing an additional 19,454 shares during the last quarter. Finally, Citadel Advisors LLC purchased a new position in 111 in the second quarter valued at approximately $107,000. 21.32% of the stock is owned by institutional investors.

About 111

111, Inc, together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers.